Pricing Log in Create free account
Saturday 17 October 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%
Market cap
$17.3B
P/E
72.7×
Fwd P/E
37.5×
Dividend yield
0.23%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Revvity Inc. (RVTY) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Revvity Inc. (RVTY) trades at a EV/Sales of 6.6×. Over the past ten years it has ranged from 2.6× (February 2016) to 7.8× (August 2022); the current reading is higher than 91% of that period. That is above the Diagnostics & Research industry median of 5.5× and above the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 4.8× (16.53%)
FY2024 5.7× (2.52%)
FY2023 5.8× (11.03%)
FY2022 6.6× (9.39%)
FY2021 7.2× 9.70%
FY2020 6.6× 50.65%
FY2019 4.4× 16.97%
FY2018 3.7× (14.75%)
FY2017 4.4× 43.35%
FY2016 3.1× (5.09%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 5.0× 19.78%
Mar 2026 4.2× (11.95%)
Dec 2025 4.8× 7.86%
Sep 2025 4.4× (9.24%)
42 more quarters

Against its own ten years

Low 2.6× High 7.8×
Ten-year median 4.6×
Current reading's percentile 90

EV/Sales against peers

Company EV/Sales
ICLR ICON PLC compare 1.9×
LH Labcorp Holdings Inc. compare 2.2×
DGX Quest Diagnostics Incorporated compare 2.7×
CRL Charles River Laboratories International, Inc. compare 4.2×
QGEN QIAGEN N.V. compare 4.9×
MEDP Medpace Holdings, Inc. compare 6.1×
RVTY Revvity Inc. 6.6×
GH Guardant Health, Inc. compare 18.2×
TWST Twist Bioscience Corporation compare 18.8×
Diagnostics & Research industry median 5.5×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on RVTY